key: cord-0322308-ar55dob2 authors: Wang, W.; Balfe, P.; Eyre, D. W.; Lumley, S. F.; O'Donnell, D.; Warren, F.; Crook, D. W.; Jeffery, K.; Matthews, P. C.; Klerman, E. B.; McKeating, J. title: Time of day of vaccination affects SARS-CoV-2 antibody responses in an observational study of healthcare workers date: 2021-10-29 journal: nan DOI: 10.1101/2021.10.28.21265499 sha: a5904dec43cef56b16b36a8ce8961f5a0705e2d4 doc_id: 322308 cord_uid: ar55dob2 The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global crisis with unprecedented challenges for public health. Vaccinations against SARS-CoV-2 have slowed the incidence of new infections and reduced disease severity. As the time-of-day of vaccination has been reported to influence host immune responses to multiple pathogens, we quantified the influence of SARS-CoV-2 vaccination time, vaccine type, age, sex, and days post-vaccination on anti-Spike antibody responses in healthcare workers. The magnitude of the anti-Spike antibody response associated with the time-of-day of vaccination, vaccine type, participant age, sex, and days post vaccination. These results may be relevant for optimizing SARS-CoV-2 vaccine efficacy. The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global crisis with unprecedented challenges for public health. Vaccinations against SARS-CoV-2 have slowed the incidence of new infections and reduced disease severity. As the time-of-day of vaccination has been reported to influence host immune responses to multiple pathogens, we quantified the influence of SARS-CoV-2 vaccination time, vaccine type, age, sex, and days postvaccination on anti-Spike antibody responses in healthcare workers. The magnitude of the anti-Spike antibody response associated with the time-of-day of vaccination, vaccine type, participant age, sex, and days post vaccination. These results may be relevant for optimizing SARS-CoV-2 vaccine efficacy. The circadian clock is an endogenous 24 hour clock that regulates many aspects of physiology, including the response to infectious disease and vaccination (Allada and Bass, 2021) . A recent report demonstrated significant daytime variation in multiple immune parameters in >300,000 participants in the UK Biobank, highlighting the diurnal nature of innate and adaptive immune responses (Wyse et al., 2021) . Human lung diseases frequently show time-ofday variation in symptom severity and respiratory function and the circadian transcriptional activator BMAL1 has been shown to regulate respiratory inflammation (Ehlers et al., 2018; Ince et al., 2019) . Influenza A virus infection of circadian-arrhythmic mice is associated with elevated inflammatory responses and a higher viral burden (Edgar et al., 2016; Sengupta et al., 2019) . The timeof-day of influenza vaccination in elderly men affected antibody responses with higher titres noted in the morning (Phillips et al., 2008; Long et al., 2016) . An additional influenza vaccination study reported that the time of sample collection rather than vaccination had a more significant effect on antibody responses . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101 /2021 .10.28.21265499 doi: medRxiv preprint (Kurupati et al., 2017 . We and others have proposed a role for circadian signalling in regulating SARS-CoV-2 host immune responses and COVID-19 severity (Ray and Reddy, 2020; Maidstone et al., 2021; Sengupta et al., 2021) . Clearly, it is important to assess whether the time of SARS-CoV-2 vaccination impacts host antibody responses. In the UK, healthcare workers were identified as a priority group to receive SARS-CoV-2 vaccine starting in December 2020. At this time, the Alpha B. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Data from 2784 participants (Table 1A) Using a linear mixed-model approach, we found that anti-Spike responses were higher in those who were vaccinated later in the day (p=0.013), in those who received the Pfizer mRNA vaccine (p<0.0001), in women (p=0.013) and in younger participants (p<0.0001) (Table 1B) . We observed significant interactions between days post-vaccination and vaccine type (p<0.0001) and age (p=0.032), but not with vaccine time (p=0.238). Analysing the data using two time intervals (before or after 1 pm) gave similar results. We did not observe a significant effect of time of day of sample collection (using the same time intervals as for vaccination times) (p=0.097), and this parameter was not included in the final model; results from the model including sample times are shown in Supplemental Table 1 . Sixty seven samples gave values beneath the cut-off (<50) in the anti-Spike assay and were classified as "non-responders", . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101/2021.10.28.21265499 doi: medRxiv preprint we found no significant association with the time-of-day of vaccination for these samples (linear mixed-effects logistic regression, p=0.23). Our analysis of 2784 healthcare workers reveals a significant effect of the time of vaccination on anti-Spike antibody levels following the administration of two alternative SARS-CoV-2 vaccines (mRNA or Adenovirus based). A recent report studying a small cohort of healthcare workers immunised with an inactivated SARS-CoV-2 vaccine in the morning (09:00 -11:00,n=33) or afternoon (15:00 -17:00, n=30) showed increased B-cell responses and anti-Spike antibodies in participants vaccinated in the morning (Zhang et al., 2021) . This contrasts with our observations and may reflect the use of an inactivated whole virus immunogen that will likely induce polytypic responses to a range of SARS-CoV-2 encoded proteins. Our observation contrasts with earlier studies in elderly men that reported higher anti-influenza titers in the morning (Phillips et al., 2008; Long et al., 2016) . This may reflect differences between the cohorts studied, particularly with regard to immune status; we studied seronegative participants whereas responses to influenza vaccination will involve the stimulation of memory responses. Sample collection time in this study showed no significant association with anti-Spike levels, in contrast to previous reports (Kurupati et al., 2017; McNaughton et al., 2021) . These data highlight the importance of recording the time of vaccination in clinical and research studies, and highlight the importance of considering time-of-day factors in future study designs that may reduce inter-individual variance and the number of participants needed to obtain statistical significance. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101/2021.10.28.21265499 doi: medRxiv preprint as the elderly or immunocompromised. We recommend future studies address these limitations when documenting natural and vaccine-induced SARS-CoV-2 immune responses. Wilson for early discussions on this project; Tess Lambe and Merryn Voysey for their constructive comments on the paper. We also thank all OUH staff who participated in the staff testing program and the staff and medical students who ran the program. This work uses data provided by healthcare workers and CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 29, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101/2021.10.28.21265499 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 29, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Shift work is associated with positive COVID-19 status in hospitalised patients Diurnal variation in SARS-CoV-2 PCR test results: Test accuracy may vary by time of day Preliminary evidence that morning vaccination is associated with an enhanced antibody response in men Temporal Links Between Self-Reported Sleep and Antibody Responses to the Influenza Vaccine COVID-19 management in light of the circadian clock Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic Circadian control of lung inflammation in influenza infection Effect of sleep deprivation on response to immunization Seasonal and daytime variation in multiple immune parameters in humans: Evidence from 329,261 participants of the Time of day influences immune response to an inactivated vaccine against SARS-CoV-2 The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity